Pulmonary hypertension & congenital heart disease
7 trialsZENITH2025Sotatercept in High-Risk Pulmonary Arterial HypertensionSTELLAR2023Sotatercept for the Treatment of Pulmonary Arterial HypertensionFUEL2020Fontan Udenafil Exercise Longitudinal TrialMAESTRO2019Macitentan in Eisenmenger Syndrome to Restore Exercise CapacityAMBITION2015Ambrisentan and Tadalafil in Patients with Pulmonary Arterial HypertensionSERAPHIN2013Study with an Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical OutcomeBREATHE-52006Bosentan Randomised Trial of Endothelin Antagonist Therapy-5